| ID | 1662 |
|---|
| No | 1662 |
|---|
| Brand Name | OSIMITINIB |
|---|
| Ingredients | OSIMERTINIB 80 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 30 TABLETS/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS ADJUVANT THERAPY AFTER TUMOR RESECTION IN ADULT PATIENTS WITH NON SMALL CELL LUNG CANCER WHOSE TUMORS HAVE EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETIONS OR EXON 21 L858R MUTATIONS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | YELLOW TABLET |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 03 L 0953/23 |
|---|
| FDD Registration Date | 23/03/2023 |
|---|
| Expiry Date | 22/03/2026 |
|---|
